Drugs / Sacubitril/Valsartan
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07491718 | Aug 2025 → Aug 2028 expected | Tako-tsubo cardiomyopathy | University of Edinburgh | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sacubitril/Valsartan | “Participants will be randomised to receive Sacubitril/Valsartan medication first.” NCT07491718 ↗ |